Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 3 | 2025 | 228 | 1.930 |
Why?
|
| Genital Neoplasms, Female | 3 | 2021 | 114 | 1.810 |
Why?
|
| Hysterectomy | 4 | 2024 | 168 | 1.430 |
Why?
|
| Analgesia, Epidural | 2 | 2020 | 42 | 1.270 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 800 | 1.160 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2025 | 59 | 0.870 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2022 | 61 | 0.730 |
Why?
|
| Oncologists | 1 | 2021 | 38 | 0.680 |
Why?
|
| Drug Costs | 1 | 2021 | 67 | 0.650 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 500 | 0.650 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 366 | 0.570 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 50 | 0.560 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 74 | 0.540 |
Why?
|
| Telemedicine | 1 | 2021 | 229 | 0.540 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 557 | 0.520 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2017 | 92 | 0.510 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1463 | 0.430 |
Why?
|
| Postoperative Complications | 3 | 2020 | 2592 | 0.430 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 449 | 0.410 |
Why?
|
| Fallopian Tubes | 2 | 2025 | 49 | 0.410 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 228 | 0.350 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 771 | 0.340 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 367 | 0.340 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2605 | 0.330 |
Why?
|
| Female | 12 | 2025 | 49869 | 0.300 |
Why?
|
| Neoplasm Staging | 2 | 2025 | 2042 | 0.280 |
Why?
|
| Retrospective Studies | 4 | 2025 | 10273 | 0.240 |
Why?
|
| Humans | 14 | 2025 | 95799 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2020 | 1010 | 0.220 |
Why?
|
| Tertiary Care Centers | 1 | 2025 | 128 | 0.220 |
Why?
|
| Aged | 6 | 2025 | 20848 | 0.220 |
Why?
|
| Menstrual Cycle | 1 | 2025 | 59 | 0.220 |
Why?
|
| Menopause | 1 | 2025 | 90 | 0.210 |
Why?
|
| United States | 4 | 2024 | 7764 | 0.210 |
Why?
|
| Middle Aged | 7 | 2025 | 28206 | 0.210 |
Why?
|
| Geography | 2 | 2021 | 240 | 0.200 |
Why?
|
| Rural Health Services | 1 | 2021 | 17 | 0.180 |
Why?
|
| Ovary | 1 | 2022 | 267 | 0.170 |
Why?
|
| Decision Trees | 1 | 2021 | 63 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2024 | 403 | 0.170 |
Why?
|
| Microsatellite Instability | 1 | 2021 | 64 | 0.170 |
Why?
|
| Markov Chains | 1 | 2021 | 137 | 0.170 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7215 | 0.170 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 99 | 0.170 |
Why?
|
| Quinolines | 1 | 2021 | 89 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2025 | 705 | 0.170 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 157 | 0.160 |
Why?
|
| Rural Population | 1 | 2021 | 171 | 0.160 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2020 | 38 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 491 | 0.160 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 277 | 0.160 |
Why?
|
| Registries | 1 | 2025 | 985 | 0.160 |
Why?
|
| Carboplatin | 1 | 2021 | 328 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 85 | 0.150 |
Why?
|
| Propensity Score | 1 | 2020 | 180 | 0.150 |
Why?
|
| Paclitaxel | 1 | 2021 | 488 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2020 | 127 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 180 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 491 | 0.150 |
Why?
|
| Pneumonia | 1 | 2020 | 196 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2018 | 98 | 0.140 |
Why?
|
| Food Supply | 1 | 2018 | 31 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 237 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 257 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 235 | 0.130 |
Why?
|
| Adult | 5 | 2025 | 28578 | 0.130 |
Why?
|
| Incidence | 1 | 2021 | 1714 | 0.130 |
Why?
|
| Operative Time | 1 | 2017 | 167 | 0.120 |
Why?
|
| Length of Stay | 1 | 2020 | 833 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2020 | 502 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2022 | 4664 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 413 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 1021 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 883 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 873 | 0.100 |
Why?
|
| Age Factors | 1 | 2018 | 1957 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1805 | 0.100 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2013 | 78 | 0.100 |
Why?
|
| Quality of Life | 1 | 2021 | 1816 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2013 | 142 | 0.090 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 206 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2018 | 3106 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 307 | 0.090 |
Why?
|
| Mutation | 1 | 2022 | 4374 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 378 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 246 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 372 | 0.080 |
Why?
|
| Calcium | 1 | 2013 | 1205 | 0.070 |
Why?
|
| Risk Factors | 1 | 2018 | 5961 | 0.070 |
Why?
|
| Lymph Node Excision | 1 | 2024 | 234 | 0.050 |
Why?
|
| Postmenopause | 1 | 2022 | 107 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 287 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 445 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 770 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1535 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 604 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 157 | 0.030 |
Why?
|
| Food | 1 | 2018 | 93 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 125 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2025 | 1730 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2018 | 338 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1176 | 0.030 |
Why?
|
| Calmodulin | 1 | 2013 | 51 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 123 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2013 | 202 | 0.020 |
Why?
|
| Protons | 1 | 2013 | 104 | 0.020 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 81 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 435 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 509 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 122 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1809 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 3581 | 0.010 |
Why?
|
| Male | 1 | 2018 | 45685 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 28889 | 0.010 |
Why?
|